"High-Risk" Clinical and Inflammatory Clusters in COPD of Chinese Descent

Pei Yee Tiew1, Fanny Wai San Ko2, Jayanth Kumar Narayana3

  • 1Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Department of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore.

Chest
|February 25, 2020
PubMed

Insights

Researchers identified five distinct clusters of Chinese patients with Chronic Obstructive Pulmonary Disease (COPD), with cardiovascular and tuberculosis clusters showing higher mortality and inflammation. This highlights the need for targeted interventions in COPD management.

Area of Science:

  • Pulmonary Medicine
  • Clinical Research
  • Genetics and Genomics

Background:

  • Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous condition with significant prevalence in Chinese populations across Southeast Asia.
  • Limited understanding exists regarding distinct COPD patient clusters and their prognostic implications within this demographic.
  • This study addresses the need to identify COPD subtypes and their association with systemic inflammation and clinical outcomes in Chinese patients.

Purpose of the Study:

  • To determine if distinct clusters of Chinese patients with COPD exist.
  • To investigate the association of these clusters with systemic inflammation.
  • To evaluate the prognostic outcomes, including mortality, associated with identified COPD patient clusters.

Main Methods:

  • Prospective recruitment of 1,480 Chinese patients with stable COPD across six hospitals in Singapore, Malaysia, and Hong Kong.
  • Unsupervised hierarchical clustering of clinical data, including comorbidities, followed by validation to identify patient clusters.
  • Systemic cytokine assessments in a subset of patients (n=336) to characterize inflammatory patterns within clusters.

Main Results:

  • Five distinct COPD patient clusters were identified: ex-tuberculosis (TB), diabetic, low comorbidity-low risk, low comorbidity-high risk, and cardiovascular.
  • The cardiovascular and ex-TB clusters exhibited the highest mortality rates, independent of Global Initiative for Chronic Obstructive Lung Disease (GOLD) assessment.
  • These high-mortality clusters demonstrated diverse cytokine patterns and complex inflammatory networks.

Conclusions:

  • Distinct clusters of Chinese COPD patients exist, with two identified as high-risk.
  • Cardiovascular and ex-TB clusters are associated with high mortality, significant inflammation, and complex inflammatory networks.
  • Clinical and inflammatory risk stratification is recommended for targeted interventions to improve outcomes in Chinese COPD patients.
Abstract

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.4K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.1K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.1K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.4K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.0K